Occudo Quantitative Strategies’s Cintas CTAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18M Sell
105,812
-6,289
-6% -$1.09M 0.96% 8
2026
Q1
$19.6M Buy
112,101
+22,792
+26% +$4.37M 1.07% 5
2025
Q4
$16.8M Buy
89,309
+75,311
+538% +$14.2M 1.13% 5
2025
Q3
$2.87M Buy
13,998
+11,337
+426% +$2.42M 0.35% 68
2025
Q2
$593K Sell
2,661
-36,127
-93% -$7.78M 0.07% 327
2025
Q1
$7.88M Buy
38,788
+32,587
+526% +$6.49M 1.05% 3
2024
Q4
$1.13M Buy
+6,201
New +$1.3M 0.2% 137
2024
Q2
Sell
-11,828
Closed -$2.03M 793
2024
Q1
$2.03M Sell
11,828
-15,452
-57% -$2.38M 0.36% 65
2023
Q4
$4.11M Buy
+27,280
New +$3.66M 0.56% 33
2023
Q3
Sell
-33,796
Closed -$4.2M 1034
2023
Q2
$4.2M Buy
33,796
+25,828
+324% +$3.03M 0.44% 16
2023
Q1
$922K Buy
+7,968
New +$878K 0.08% 339
2021
Q2
Sell
-9,960
Closed -$850K 903
2021
Q1
$850K Buy
+9,960
New +$843K 0.19% 163

Other funds holding CTAS

Occudo Quantitative Strategies's CTAS Position: Q2 2026 in Review

Occudo Quantitative Strategies reduced its Cintas (CTAS) stake by 5.6% in Q2 2026, selling an estimated $1.09M and leaving 105,812 shares worth $18M. The position accounts for 0.96% of the portfolio, ranked #8.

Occudo Quantitative Strategies first reported a position in CTAS in Q1 2021 and has held it in 12 quarters since. The position peaked at $19.6M in Q1 2026. 1,420 funds tracked by Wall St. Rank hold CTAS as of Q2 2026.

  • Occudo Quantitative Strategies held 105,812 shares of Cintas worth $18M as of Q2 2026.
  • Occudo Quantitative Strategies sold 6,289 Cintas shares in Q2 2026, an estimated $1.09M.
  • Cintas made up 0.96% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #8 holding.
  • Occudo Quantitative Strategies first reported a position in Cintas in Q1 2021 and has held it in 12 quarters since.
  • Occudo Quantitative Strategies's Cintas position peaked at $19.6M in Q1 2026.
  • 1,420 funds tracked by Wall St. Rank held Cintas as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.